# Repaglinide

NDC: 65862-670
Generic name: Repaglinide
Labeler / Manufacturer: Aurobindo Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20140122

FDA application: ANDA203820

## Active ingredients

- REPAGLINIDE: .5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"65862-670"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=65862-670
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=68064989-47ea-4ed5-a20e-43c4ef6ec271